Pharmaresearch Bio Co (XKRX:217950) Construction In Progress : ₩5,381 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co Construction In Progress?

Pharmaresearch Bio Co's quarterly construction in progress stayed the same from Dec. 2021 (₩0 Mil) to Dec. 2022 (₩0 Mil) but then increased from Dec. 2022 (₩0 Mil) to Dec. 2023 (₩5,381 Mil).

Pharmaresearch Bio Co's annual construction in progress stayed the same from Dec. 2021 (₩0 Mil) to Dec. 2022 (₩0 Mil) but then increased from Dec. 2022 (₩0 Mil) to Dec. 2023 (₩5,381 Mil).

Pharmaresearch Bio Co Construction In Progress Historical Data

The historical data trend for Pharmaresearch Bio Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co Construction In Progress Chart

Pharmaresearch Bio Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

5,380.81

Pharmaresearch Bio Co Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Construction In Progress	Get a 7-Day Free Trial			-	-	-	-	5,380.81

Pharmaresearch Bio Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Pharmaresearch Bio Co (XKRX:217950) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

N/A

Address

641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494

Website

http://www.pr-bio.co.kr

Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co (XKRX:217950) Headlines

No Headlines